AsiaMedic to acquire LuyeEllium Healthcare for S$42.2 million
Add BT as a preferred source
ASIAMEDIC has entered into a conditional sale and purchase agreement with the shareholders of LuyeEllium Healthcare to acquire the company for S$42.2 million.
LuyeEllium provides hospital management services to hospitals in South Korea and China.
The consideration will be fulfilled via the issuance of 527.1 million new shares, at the issue price of eight Singapore cents per share.
Upon completion of the proposed acquisition, it will be a wholly owned subsidiary of the AsiaMedic.
AsiaMedic will be appointing an independent valuer to prepare a valuation report on LuyeEllium.
Share with us your feedback on BT's products and services
TRENDING NOW
Trickier across borders: Why commercial disputes are getting more complex
Too little, too late? Manila’s billion-dollar bid to ignite its sputtering EV industry
When every phone becomes a satellite phone, what happens to Asia’s telcos?
How BYD disrupted Singapore’s car market – and why the strategy is turning on itself
